Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.
Identifieur interne : 000142 ( Main/Exploration ); précédent : 000141; suivant : 000143Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.
Auteurs : M L Wumkes [Pays-Bas] ; A M T. Van Der Velden ; A W G. Van Der Velden ; J M L. Stouthard ; M R Nijziel ; M. Westerman ; A. Beeker ; A. Meerveld-Eggink ; G T Rijkers ; D H BiesmaSource :
- The Netherlands journal of medicine [ 1872-9061 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antinéoplasiques (effets indésirables), Antinéoplasiques (usage thérapeutique), Connaissances, attitudes et pratiques en santé (MeSH), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Grippe humaine (immunologie), Grippe humaine (prévention et contrôle), Humains (MeSH), Mâle (MeSH), Médecins généralistes (psychologie), Médecins généralistes (statistiques et données numériques), Pays-Bas (MeSH), Sujet âgé (MeSH), Tumeurs colorectales (immunologie), Tumeurs colorectales (traitement médicamenteux), Tumeurs du sein (immunologie), Tumeurs du sein (traitement médicamenteux), Types de pratiques des médecins (statistiques et données numériques), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- effets indésirables : Antinéoplasiques.
- immunologie : Grippe humaine, Tumeurs colorectales, Tumeurs du sein, Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- psychologie : Médecins généralistes.
- statistiques et données numériques : Médecins généralistes, Types de pratiques des médecins.
- traitement médicamenteux : Tumeurs colorectales, Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques.
- Adulte d'âge moyen, Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Femelle, Humains, Mâle, Pays-Bas, Sujet âgé.
- Wicri :
- geographic : Pays-Bas.
English descriptors
- KwdEn :
- Aged (MeSH), Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Breast Neoplasms (drug therapy), Breast Neoplasms (immunology), Colorectal Neoplasms (drug therapy), Colorectal Neoplasms (immunology), Female (MeSH), General Practitioners (psychology), General Practitioners (statistics & numerical data), Health Knowledge, Attitudes, Practice (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Netherlands (MeSH), Practice Patterns, Physicians' (statistics & numerical data), Surveys and Questionnaires (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Antineoplastic Agents.
- chemical , immunology : Influenza Vaccines.
- chemical , therapeutic use : Antineoplastic Agents.
- geographic : Netherlands.
- drug therapy : Breast Neoplasms, Colorectal Neoplasms.
- immunology : Breast Neoplasms, Colorectal Neoplasms, Influenza, Human.
- prevention & control : Influenza, Human.
- psychology : General Practitioners.
- statistics & numerical data : General Practitioners, Practice Patterns, Physicians'.
- Aged, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Surveys and Questionnaires.
Abstract
BACKGROUND
Influenza virus vaccination is recommended for patients treated with chemotherapy. Little is known about vaccination coverage in these patients.
METHODS
Vaccination coverage in the Netherlands was analysed by questionnaires completed by general practitioners, within a catchment area of 1.3 million people, in the period 2010-2011.
RESULTS
Of 433 eligible adult patients treated with chemotherapy for breast or colorectal cancer, 144 patients gave permission for us to approach their general practitioner with a questionnaire. General practitioners were asked about vaccination coverage, awareness of recommendations and their opinion about the responsibility for vaccination. We received 114 (79%) completed questionnaires. Sixty-seven out of 114 patients (59%) were vaccinated against influenza. Forty-four (66%) of these patients also had an indication for vaccination based on age (age ≥60 years). According to 48% of the general practitioners, the responsibility for vaccination belongs to the competence of the treating medical oncologist.
CONCLUSION
Influenza vaccination coverage is limited to 59% of patients treated with chemotherapy. Guidelines for responsibility (general practitioner or medical oncologist) may increase the vaccination rate of cancer patients.
PubMed: 24218421
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.</title><author><name sortKey="Wumkes, M L" sort="Wumkes, M L" uniqKey="Wumkes M" first="M L" last="Wumkes">M L Wumkes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Tergooi Hospitals Hilversum, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Internal Medicine, Tergooi Hospitals Hilversum</wicri:regionArea><wicri:noRegion>Tergooi Hospitals Hilversum</wicri:noRegion></affiliation></author><author><name sortKey="Van Der Velden, A M T" sort="Van Der Velden, A M T" uniqKey="Van Der Velden A" first="A M T" last="Van Der Velden">A M T. Van Der Velden</name></author><author><name sortKey="Van Der Velden, A W G" sort="Van Der Velden, A W G" uniqKey="Van Der Velden A" first="A W G" last="Van Der Velden">A W G. Van Der Velden</name></author><author><name sortKey="Stouthard, J M L" sort="Stouthard, J M L" uniqKey="Stouthard J" first="J M L" last="Stouthard">J M L. Stouthard</name></author><author><name sortKey="Nijziel, M R" sort="Nijziel, M R" uniqKey="Nijziel M" first="M R" last="Nijziel">M R Nijziel</name></author><author><name sortKey="Westerman, M" sort="Westerman, M" uniqKey="Westerman M" first="M" last="Westerman">M. Westerman</name></author><author><name sortKey="Beeker, A" sort="Beeker, A" uniqKey="Beeker A" first="A" last="Beeker">A. Beeker</name></author><author><name sortKey="Meerveld Eggink, A" sort="Meerveld Eggink, A" uniqKey="Meerveld Eggink A" first="A" last="Meerveld-Eggink">A. Meerveld-Eggink</name></author><author><name sortKey="Rijkers, G T" sort="Rijkers, G T" uniqKey="Rijkers G" first="G T" last="Rijkers">G T Rijkers</name></author><author><name sortKey="Biesma, D H" sort="Biesma, D H" uniqKey="Biesma D" first="D H" last="Biesma">D H Biesma</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24218421</idno><idno type="pmid">24218421</idno><idno type="wicri:Area/Main/Corpus">000128</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000128</idno><idno type="wicri:Area/Main/Curation">000128</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000128</idno><idno type="wicri:Area/Main/Exploration">000128</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.</title><author><name sortKey="Wumkes, M L" sort="Wumkes, M L" uniqKey="Wumkes M" first="M L" last="Wumkes">M L Wumkes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Tergooi Hospitals Hilversum, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Internal Medicine, Tergooi Hospitals Hilversum</wicri:regionArea><wicri:noRegion>Tergooi Hospitals Hilversum</wicri:noRegion></affiliation></author><author><name sortKey="Van Der Velden, A M T" sort="Van Der Velden, A M T" uniqKey="Van Der Velden A" first="A M T" last="Van Der Velden">A M T. Van Der Velden</name></author><author><name sortKey="Van Der Velden, A W G" sort="Van Der Velden, A W G" uniqKey="Van Der Velden A" first="A W G" last="Van Der Velden">A W G. Van Der Velden</name></author><author><name sortKey="Stouthard, J M L" sort="Stouthard, J M L" uniqKey="Stouthard J" first="J M L" last="Stouthard">J M L. Stouthard</name></author><author><name sortKey="Nijziel, M R" sort="Nijziel, M R" uniqKey="Nijziel M" first="M R" last="Nijziel">M R Nijziel</name></author><author><name sortKey="Westerman, M" sort="Westerman, M" uniqKey="Westerman M" first="M" last="Westerman">M. Westerman</name></author><author><name sortKey="Beeker, A" sort="Beeker, A" uniqKey="Beeker A" first="A" last="Beeker">A. Beeker</name></author><author><name sortKey="Meerveld Eggink, A" sort="Meerveld Eggink, A" uniqKey="Meerveld Eggink A" first="A" last="Meerveld-Eggink">A. Meerveld-Eggink</name></author><author><name sortKey="Rijkers, G T" sort="Rijkers, G T" uniqKey="Rijkers G" first="G T" last="Rijkers">G T Rijkers</name></author><author><name sortKey="Biesma, D H" sort="Biesma, D H" uniqKey="Biesma D" first="D H" last="Biesma">D H Biesma</name></author></analytic><series><title level="j">The Netherlands journal of medicine</title><idno type="eISSN">1872-9061</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (immunology)</term><term>Colorectal Neoplasms (drug therapy)</term><term>Colorectal Neoplasms (immunology)</term><term>Female (MeSH)</term><term>General Practitioners (psychology)</term><term>General Practitioners (statistics & numerical data)</term><term>Health Knowledge, Attitudes, Practice (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Netherlands (MeSH)</term><term>Practice Patterns, Physicians' (statistics & numerical data)</term><term>Surveys and Questionnaires (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Antinéoplasiques (effets indésirables)</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Connaissances, attitudes et pratiques en santé (MeSH)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Médecins généralistes (psychologie)</term><term>Médecins généralistes (statistiques et données numériques)</term><term>Pays-Bas (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Tumeurs colorectales (immunologie)</term><term>Tumeurs colorectales (traitement médicamenteux)</term><term>Tumeurs du sein (immunologie)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Types de pratiques des médecins (statistiques et données numériques)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Colorectal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Tumeurs colorectales</term><term>Tumeurs du sein</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Breast Neoplasms</term><term>Colorectal Neoplasms</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Médecins généralistes</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>General Practitioners</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>General Practitioners</term><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Médecins généralistes</term><term>Types de pratiques des médecins</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs colorectales</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Connaissances, attitudes et pratiques en santé</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Pays-Bas</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Influenza virus vaccination is recommended for patients treated with chemotherapy. Little is known about vaccination coverage in these patients.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Vaccination coverage in the Netherlands was analysed by questionnaires completed by general practitioners, within a catchment area of 1.3 million people, in the period 2010-2011.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Of 433 eligible adult patients treated with chemotherapy for breast or colorectal cancer, 144 patients gave permission for us to approach their general practitioner with a questionnaire. General practitioners were asked about vaccination coverage, awareness of recommendations and their opinion about the responsibility for vaccination. We received 114 (79%) completed questionnaires. Sixty-seven out of 114 patients (59%) were vaccinated against influenza. Forty-four (66%) of these patients also had an indication for vaccination based on age (age ≥60 years). According to 48% of the general practitioners, the responsibility for vaccination belongs to the competence of the treating medical oncologist.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Influenza vaccination coverage is limited to 59% of patients treated with chemotherapy. Guidelines for responsibility (general practitioner or medical oncologist) may increase the vaccination rate of cancer patients.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24218421</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>04</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1872-9061</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>9</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Netherlands journal of medicine</Title><ISOAbbreviation>Neth J Med</ISOAbbreviation></Journal><ArticleTitle>Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.</ArticleTitle><Pagination><MedlinePgn>472-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Influenza virus vaccination is recommended for patients treated with chemotherapy. Little is known about vaccination coverage in these patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Vaccination coverage in the Netherlands was analysed by questionnaires completed by general practitioners, within a catchment area of 1.3 million people, in the period 2010-2011.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 433 eligible adult patients treated with chemotherapy for breast or colorectal cancer, 144 patients gave permission for us to approach their general practitioner with a questionnaire. General practitioners were asked about vaccination coverage, awareness of recommendations and their opinion about the responsibility for vaccination. We received 114 (79%) completed questionnaires. Sixty-seven out of 114 patients (59%) were vaccinated against influenza. Forty-four (66%) of these patients also had an indication for vaccination based on age (age ≥60 years). According to 48% of the general practitioners, the responsibility for vaccination belongs to the competence of the treating medical oncologist.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Influenza vaccination coverage is limited to 59% of patients treated with chemotherapy. Guidelines for responsibility (general practitioner or medical oncologist) may increase the vaccination rate of cancer patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wumkes</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tergooi Hospitals Hilversum, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Velden</LastName><ForeName>A M T</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>van der Velden</LastName><ForeName>A W G</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Stouthard</LastName><ForeName>J M L</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Nijziel</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Westerman</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Beeker</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Meerveld-Eggink</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rijkers</LastName><ForeName>G T</ForeName><Initials>GT</Initials></Author><Author ValidYN="Y"><LastName>Biesma</LastName><ForeName>D H</ForeName><Initials>DH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neth J Med</MedlineTA><NlmUniqueID>0356133</NlmUniqueID><ISSNLinking>0300-2977</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24218421</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><noCountry><name sortKey="Beeker, A" sort="Beeker, A" uniqKey="Beeker A" first="A" last="Beeker">A. Beeker</name><name sortKey="Biesma, D H" sort="Biesma, D H" uniqKey="Biesma D" first="D H" last="Biesma">D H Biesma</name><name sortKey="Meerveld Eggink, A" sort="Meerveld Eggink, A" uniqKey="Meerveld Eggink A" first="A" last="Meerveld-Eggink">A. Meerveld-Eggink</name><name sortKey="Nijziel, M R" sort="Nijziel, M R" uniqKey="Nijziel M" first="M R" last="Nijziel">M R Nijziel</name><name sortKey="Rijkers, G T" sort="Rijkers, G T" uniqKey="Rijkers G" first="G T" last="Rijkers">G T Rijkers</name><name sortKey="Stouthard, J M L" sort="Stouthard, J M L" uniqKey="Stouthard J" first="J M L" last="Stouthard">J M L. Stouthard</name><name sortKey="Van Der Velden, A M T" sort="Van Der Velden, A M T" uniqKey="Van Der Velden A" first="A M T" last="Van Der Velden">A M T. Van Der Velden</name><name sortKey="Van Der Velden, A W G" sort="Van Der Velden, A W G" uniqKey="Van Der Velden A" first="A W G" last="Van Der Velden">A W G. Van Der Velden</name><name sortKey="Westerman, M" sort="Westerman, M" uniqKey="Westerman M" first="M" last="Westerman">M. Westerman</name></noCountry><country name="Pays-Bas"><noRegion><name sortKey="Wumkes, M L" sort="Wumkes, M L" uniqKey="Wumkes M" first="M L" last="Wumkes">M L Wumkes</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000142 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000142 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24218421
|texte= Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24218421" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |